Abstract
Reply: How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have